ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1553

Circulating Monocyte Level Is Associated With Pulmonary Vascular Disease and Right Ventricular Dysfunction in Systemic Sclerosis

Ai Yaku1, Bong Joon Kim2, Hidenori Yaku1, Carrie Richardson2, Michael Cuttica2, Ruben Mylvaganam2, Vera Rigolin2, Matthew Feinstein2 and Sanjiv Shah1, 1Northwestern University, Chicago, IL, 2Northwestern University, Chicago

Meeting: ACR Convergence 2025

Keywords: Cardiovascular, Inflammation, Monocytes/macrophages, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1553–1591) Systemic Sclerosis & Related Disorders – Clinical Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Pulmonary arterial hypertension associated with systemic sclerosis (SSc-PAH) is a life-threatening condition with obliterative pulmonary vascular remodeling, right ventricular (RV) dysfunction, and poor prognosis. Despite therapeutic advances, SSc-PAH remains a critical unmet clinical need due to its complex pathophysiology and lack of effective treatments. Chronic inflammation and immune dysregulation are believed to play a pivotal role in disease progression, but specific immune mechanisms remain poorly understood. Early detection of pulmonary hypertension (PH) and RV dysfunction is also a major challenge in clinical practice. To address this, we employed exercise echocardiography to unmask early RV dysfunction and PH and sought to elucidate the relationship between circulating immune subsets and PH and RV dysfunction severity in patients with SSc.

Methods: We prospectively enrolled 96 participants: 41 SSc-PH patients, 23 SSc-nonPH patients, 15 idiopathic PAH patients, and 17 age- and sex-matched controls. All participants underwent resting and exercise echocardiography, 6-minute walk test, electrocardiography, clinical assessments, and blood tests. We evaluated associations between immune cell subsets in peripheral blood and echocardiographic parameters of PH severity and RV function both at rest and during exercise, using univariate and multivariate linear regression models adjusted for age, sex, SSc subtype, and disease duration.

Results: Immune cell subset distributions did not differ significantly among the groups. However, increased monocyte percentage in SSc patients was associated with greater RV end-diastolic area, higher tricuspid regurgitation velocity peak velocity (TRV)/RV outflow tract velocity time integral (RVOT-VTI) which is an echo estimate of total pulmonary resistance, and reduced tricuspid annular plane systolic excursion (TAPSE)/TRV ratio which is an indicator of worse RV-pulmonary arterial coupling (Figure 1). These associations remained significant after adjustment for covariates. Exercise echocardiography revealed that most SSc patients (81%) had RV dysfunction, including subclinical RV dysfunction (change in absolute RV strain from rest to exercise [ΔRV strain ] < 0) or clinical RV dysfunction (absolute resting RV strain < 20%) (Figure 2). Notably, higher monocyte percentage was associated with worse RV contractile reserve (ΔRV strain from rest to 25W exercise): multivariable β = -1.71, 95% CI: -3.31 to -0.113, p = 0.037.

Conclusion: Increased levels of circulating monocytes are associated with greater PH severity and RV dysfunction in SSc. Dysregulation of the innate immune system potentially links cardiopulmonary dysfunction/remodeling in SSc.

Supporting image 1

Supporting image 2


Disclosures: A. Yaku: None; B. Kim: None; H. Yaku: None; C. Richardson: Cabaletta Bio, 2; M. Cuttica: None; R. Mylvaganam: Janssen, 2, Roivant Sciences, 2, United Therapuetics, 2, 6; V. Rigolin: Amgen, 11, AstraZeneca, 11, Bristol-Myers Squibb(BMS), 11, Edwards Lifesciences, 11, Merck/Schering Plough, 11, Pfizer, 11, Regeneron, 11, Viatris, 11; M. Feinstein: None; S. Shah: None.

To cite this abstract in AMA style:

Yaku A, Kim B, Yaku H, Richardson C, Cuttica M, Mylvaganam R, Rigolin V, Feinstein M, Shah S. Circulating Monocyte Level Is Associated With Pulmonary Vascular Disease and Right Ventricular Dysfunction in Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/circulating-monocyte-level-is-associated-with-pulmonary-vascular-disease-and-right-ventricular-dysfunction-in-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/circulating-monocyte-level-is-associated-with-pulmonary-vascular-disease-and-right-ventricular-dysfunction-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology